| Literature DB >> 29786969 |
Adamantia F Fragopoulou1,2, Alexandros Polyzos3, Maria-Despoina Papadopoulou3, Anna Sansone4, Areti K Manta1, Evangelos Balafas5, Nikolaos Kostomitsopoulos5, Aikaterini Skouroliakou6, Chryssostomos Chatgilialoglu4,7, Alexandros Georgakilas8, Dimitrios J Stravopodis1, Carla Ferreri4, Dimitris Thanos3, Lukas H Margaritis1.
Abstract
BACKGROUND: The widespread use of wireless devices during the last decades is raising concerns about adverse health effects of the radiofrequency electromagnetic radiation (RF-EMR) emitted from these devices. Recent research is focusing on unraveling the underlying mechanisms of RF-EMR and potential cellular targets. The "omics" high-throughput approaches are powerful tools to investigate the global effects of RF-EMR on cellular physiology.Entities:
Keywords: brain; fatty acids; gene expression; membrane remodeling; radiofrequencies
Mesh:
Substances:
Year: 2018 PMID: 29786969 PMCID: PMC5991598 DOI: 10.1002/brb3.1001
Source DB: PubMed Journal: Brain Behav Impact factor: 2.708
Fatty acid methyl esters (FAME) (means ± SD) expressed as relative percentages (% rel) based on the total fatty acid peaks appeared in the gas chromatography (GC) analysis with >98% resolved fatty acid (FA) peaks/as detected by GC analysis of the lipid extracts obtained from the hippocampus homogenates of sham‐exposed (SE) and exposed (Exp) mice (see Fig. S2 for a representative GC analysis)
| FAME | SE ( | Exp ( |
|---|---|---|
| Mean ± SD (% rel) | Mean ± SD (% rel) | |
| 14:0 | 1.1 ± 0.3 | 1.3 ± 0.9 |
| 16:0 |
|
|
| 16:1 (6c+7c) |
|
|
| 16:1 9c | 1.6 ± 0.6 | 1.5 ± 0.3 |
| 18:0 | 20.0 ± 2.6 | 18.3 ± 3.2 |
| 18:1 9c |
|
|
| 18:1 11c | 3.3 ± 0.6 | 3.7 ± 1.0 |
| 18:2 ω6 | 3.9 ± 2.4 | 2.8 ± 1.1 |
| 18:3 ω3 | 0.7 ± 0.6 | 0.6 ± 0.2 |
| 20:3 ω6 | 0.9 ± 0.4 | 0.8 ± 0.2 |
| 20:4 ω6 | 4.8 ± 2.2 | 5.2 ± 0.8 |
| 20:5 ω3 |
|
|
| 22:5 ω3 | 0.5 ± 0.1 | 0.5 ± 0.1 |
| 22:6 ω3 | 6.5 ± 2.8 | 7.1 ± 3.0 |
| SFA |
|
|
| MUFA |
|
|
| PUFA | 18.8 ± 2.0 | 18.2 ± 1.9 |
| TOT trans | 0.4 ± 0.2 | 0.4 ± 0.1 |
FAME, fatty acid methyl esters; SE, sham‐exposed; SFA, saturated fatty acids (SFA); MUFA, monounsaturated fatty acids. The bold character in the table indicates the fatty acid values with statistical significance.
†Sum of positional isomers 16:1 6 cis + 16:1 7 cis. The two positional isomers overlapped in only one peak in our GC conditions; we determined the presence of both positional isomers by recognition of diagnostic fragmentations after GC‐MS injection of their dimethyldisulfide (DMDS) adducts (Nichols et al., 1989). ‡TOT trans: the sum of geometrical trans isomers as determined by the analytical protocol previously described (Sansone et al., 2016).
a p = 0.021, b p = 0.038, c p = 0.028, d p = 0.004, e p = 0.028, f p = 0.01.
Figure 1The graph depicts the fatty acid residues found in the hippocampus tissues of the exposed (Exp) and the sham‐exposed (SE) mice. Values are expressed as % rel (as reported in Table 1), and only, the statistically significant different fatty acids are reported. *p ≤ 0.05, **p ≤ 0.01
Unsaturation Index (UI) and Peroxidation Index (PI) obtained from the data of Table 1 according to known equations for the calculated values (Puca et al., 2008). Data are shown as means ± SD. SE: Sham‐exposed mice; Exp = exposed to mobile phone radiation mice
| SE | Exp |
|---|---|
| UI | |
| 98.9 ± 20.1 | 102.3 ± 18.3 |
| PI | |
| 89.3 ± 25.2 | 89.5 ± 25.6 |
SE, sham‐exposed; Exp, exposed.
Figure 2(a) Heat‐map showing normalized expression levels of 178 identified DEGs (≥1.5 fold, p ≤ 0.05, Welch’s t test). Mobile phone radiation alters gene expression profile in mouse hippocampus mainly through a transcriptional activation process. Gene clustering was performed using Euclidean distance and average linkage analysis software. Red color indicates upregulated genes (118), while blue color specifies downregulated genes (60). SE: Sham‐exposed. Exp: Exposed. SE1, SE2, Exp1, and Exp2 refer to four pooled hippocampi each from four different mice. (b) Heat map of the six DEGs that were selected from the microarray experiment for qRT‐PCR verification. (c) Bar graph presenting average normalized mRNA levels ± SD (Exp1 and Exp2 vs. SE1 and SE2). *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001
Figure 3Gene ontology (GO) annotation and cluster classification analysis of mobile phone radiation DEGs in mouse hippocampus using the DAVID knowledgebase bioinformatics tools. DEGs were categorized according to (a) “cellular compartmentalization,” (b) “biological processes,” and (c) “molecular functions.” The number of genes that could be classified in each different category is indicated
Figure 4Canonical pathways analysis and identification of upstream regulators. (a) Bar graphs denote functional pathways that were significantly (p ≤ 0.05) affected in hippocampus by exposure of mice to mobile phone radiation. Ratio is referred to the number of genes from our DEGs list divided by the total number of genes involved in each specific pathway that has been notably affected. Threshold is determined at p value 0.05 [−log (0.05) = 1.30]. (b) Network of selected upstream transcription regulators, which were considered to be active or repressed regulating the expression of the genes affected by mobile phone radiation in mouse hippocampus, were merged in a single network
Functional networks that were significantly affected by mobile phone radiation related to specific processes and diseases according to Ingenuity Pathway Analysis (IPA). Ten networks were identified and were ranked by the score in the p value calculation of the IPA assay, which ranged from 11 to 53. The higher the score number, the stronger the effect in the network. The components of these networks are shown in the “Molecules in Network” column, while the number of the genes of each network that were affected is shown in the “Focus molecules” column. The scores take into account the number of focus proteins and the size of the network to approximate the relevance of the network to the original list of focus proteins
| ID | Molecules in network | Score | Focus molecules | Top diseases and functions |
|---|---|---|---|---|
| #1 | 60S ribosomal subunit,Akt,AQR,BCAM,CCDC90B,Cops2,CREG1,DHX8,EIF2S2,FRZB,IgG2a,Laminin,MYOC,Nfat (family), Pka catalytic subunit,PTN, Rbx1, Ribosomal 40s subunit, Rnr, RPL17, RPL31, RPL38, RPL10A, RPL13A, RPL37A, RPS5, RPS16, RPS18, RPS23, RPS4Y1, RPSA, SDC4, SKP2, TCEAL9, Ubiquitin | 53 | 26 | Cancer, Cell Death and Survival, Organismal Injury and Abnormalities |
| #2 | ACP1, B4GALT6, BAIAP2, Ccl9, CDK14, Cg, DBI, DECR1, ENAH, EPHA4, EPM2A, ERK1/2, Fcer1, Growth hormone, HINT1, Ige, IGFBP6, Integrin, KIT, Lh, NSF, OVGP1, p85 (pik3r),PLC gamma, PSMB6, PTPase, PTPRJ, Rap1, RASGRP1, SNAP23, SRC (family), Syntaxin, TOPORS, USE1, VAMP7 | 42 | 22 | Cellular Assembly and Organization, Cellular Function and Maintenance, Molecular Transport |
| #3 | 26s Proteasome, Actin, ANXA1, ATE1, Calcineurin protein(s), calpain, CAPN5, CD3, CORO1A, Creb, Cyclin A, F Actin, FCGR2A, GAS5, H2AFZ, HDAC9, HISTONE, Histone h3, Histone h4, HOPX, IKBKAP, IL12 (complex), Immunoglobulin, KDM5B, KDM5D, KIF5C, NCF2, NFkB (complex), PI3K (complex), Pkc(s), PPP3CC, PVALB, RNA polymerase II, TOB2, VPS35 | 32 | 18 | Dermatological Diseases and Conditions, Gastrointestinal Disease, Immunological Disease |
| #4 | ALB, AMN, ANGEL1, ATP2B2, Calmodulin, CELF2, DAPK2, DGKG, ERK, Focal adhesion kinase, Gsk3, HAUS5, IgG, IL1, Insulin, ITPR2, Jnk, LDL, LRRTM1, LYZ, Mapk, ODF2, P38 MAPK, PDE10A, PDGF BB, Pka, PLC, Rac, Ras, Ras homolog, RND2, RYR3, SYT1, Vegf, ZFYVE21 | 30 | 17 | Nucleic Acid Metabolism, Small Molecule Biochemistry, Cellular Function and Maintenance |
| #5 | APH1A, APP, ARF3, ATG12, ATP5O, ATP6V1G1, beta‐estradiol, C1D, C4A/C4B, CFB, CLUAP1, COG1, CSRP1, cyclic GMP, DECR1, dehydroepiandrosterone sulfate, DERL1, DKK1, EGFR, FSIP1, GNRH2, GRIN2A, GTF3C6, H + ‐transporting two‐sector ATPase, MBTPS1, PPP1R3C, PRSS3, RESP18, SEC61G, SUMO1, TAC1, TRAF3IP1, UBXN10, VARS, VHL | 27 | 16 | Cancer, Protein Degradation, Protein Synthesis |
| #6 | AKR1A1, AMPD2, B3GALT1, BCO2, Brd4, CORO1B, DKK1, DMWD, EZH2, FETUB, HOXD12, HSPB1, JARID2, KRT5, Ku, LRRC40, MECOM, miR‐34a‐5p (and other miRNAs w/seed GGCAGUG), MRPL40, PGM2, PHGDH, PLEKHF1, POT1, PRKCDBP, RASGEF1C, Rian, Rpl23a, SACS, SDPR, SH3BP1, SHKBP1, SP110, TERF1, tretinoin, TRPC3 | 23 | 14 | Cell Cycle, Cancer, Cellular Development |
| #7 | ACADL, ARL16, BSCL2, CCL5, Ccl8, Ccl9, CCR10, Cd52, CFD, chemokine, CIDEA, CIDEC, CX3CL1, CXCL14, ENPP2, Ighd, IGHE, IGHM, KCTD14, LRRC20, miR‐1249‐5p (and other miRNAs w/seed GGAGGGA), NTAN1, PALB2, PLIN5, PNPLA2, PPARG, PPBP, RANBP3, RNase A, S100A8, S100a11, SLN, TAB1, THRSP, TMEM134 | 23 | 14 | Lipid Metabolism, Small Molecule Biochemistry, Molecular Transport |
| #8 | 1,3,4,5‐IP4, Acox, anandamide, ARL6, Atp5k, CDK5R1, Cebp, CHGB, Ck2, CSNK2A1, DKK1, FGA, FHL3, FNBP4, Glycogen synthase, Gm561, GNA14, IFNG, KCNS2, L‐threonine, miR‐4651 (and other miRNAs w/seed GGGGUGG), POLR1A, PRKAR2A, PRNP, RNA polymerase I, RNASE4, SCP2, SERPING1, SLC34A2, SMARCD1, ST13, TAB1, TP53, TRUB2, ZFP36 | 17 | 11 | Cell Cycle, Cellular Development, Embryonic Development |
| #9 | ABCA1, ABCA8, APOC3, CDC45, DDX24, Delta/Jagged, DKK1, DLL3, farnesyl pyrophosphate, FASTKD2, FCGRT, HMG CoA synthase, Igkv1‐117, ILF3, LYL1, mevalonic acid, MIRLET7, MSGN1, MYC, NDUFS4, NFKBIA, NOTCH1, NPM1, NUP43, Pka catalytic subunit,PPARα‐RXRα, RNF20, RPP30, RPP40, SPOCK1, TAB1, TCP1, Tmsb4x (includes others), TRAF7, Zfp68 | 17 | 11 | Lipid Metabolism, Molecular Transport, Small Molecule Biochemistry |
| #10 | ACOT7, C1QB, CAPZA2, CCDC57, CD302, CKB, CLK3, EED, HSPH1, IKBKAP, JARID2, MIPOL1, miR‐16‐5p (and other miRNAs w/seed AGCAGCA), miR‐9‐3p (and other miRNAs w/seed UAAAGCU), MMD, MRPL20, MSH2, ORMDL1, PCDHA1, PCDHAC1, PLAG1, POLR2H, RBM4, RHOT1, SCRG1, SNRPA1, SPATA5, SREK1IP1, STAG1, VILL, XPO7, ZC3H11A, ZHX1, ZMAT2, ZMYM2 | 11 | 8 | Cellular Compromise, Hematological System Development and Function, Auditory Disease |